GSK is expected to report earnings to rise 189.61% to 66 cents per share on July 27
Q2'22
Est.
$0.67
Q4'24
Missed
by $0.26
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.13
Q1'24
Beat
by $0.16
The last earnings report on February 05 showed earnings per share of 23 cents, missing the estimate of 49 cents. With 5.64M shares outstanding, the current market capitalization sits at 88.13B.